Barriers to Access in the Testing and Treatment of Patients With Biliary Tract Cancer

Rachna T. Shroff, MD, MS

October 25, 2022

Rachna T. Shroff, MD, addresses the impact of health disparities in the treatment outcomes of patients with cancer. Specifically discussing patients with biliary tract cancer, Dr Shroff focuses primarily on the barriers to access facing these patients, which includes lack of access to the specialists who treat biliary tract cancer, lack of access to important clinical trials studying new therapies, and lack of access to comprehensive biomarker testing.

To help alleviate the disparity in outcomes of patients on their cancer journey, Dr Shroff stresses the importance of having both access to and coverage for the expensive process of full biomarker testing upfront, to evaluate which targetable alterations the patient harbors and to find the most suitable treatment available to them.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Barriers to Access in the Testing and Treatment of Patients With Biliary Tract Cancer - Medscape - Oct 25, 2022.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.